Dilated cardiomyopathies and non-compaction cardiomyopathy.
Dilated cardiomyopathies and non-compaction cardiomyopathy. Herz. 2020 Feb 27;: Authors: Hänselmann A, Veltmann C, Bauersachs J, Berliner D Abstract Dilated cardiomyopathy (DCM) is the most common form of cardiomyopathy and one of the most common causes of heart failure. It is characterized by left or biventricular dilation and a reduced systolic function. The causes are manifold and range from myocarditis to alcohol and other toxins, to rheumatological, endocrinological, and metabolic diseases. Peripartum cardiomyopathy is a special form that occurs at the end of or shortly after pregnancy. Genetic mutations can be detected in approximately 30-50% of DCM patients. Owing to the growing possibilities of genetic diagnostics, increasingly more triggering variants and hereditary mechanisms emerge. This is particularly important with regard to risk stratification for patients with variants with an increased risk of arrhythmias. Patient prognosis is determined by the occurrence of heart failure and arrhythmias. In addition to the treatment of the underlying disease or the elimination of triggering harmful toxins, therapy consists in guideline-directed heart failure treatment including drug and device therapy. PMID: 32107565 [PubMed - as supplied by publisher]
Publication date: Available online 5 June 2020Source: Respiratory Physiology &NeurobiologyAuthor(s): Alessandra Magini, Mauro Contini, Emanuele Spadafora, Anna Apostolo, Elisabetta Salvioni, Simone Barbieri, Susanna Sciomer, Daniele Andreini, Fabrizio Veglia, Gerald S. Zavorsky, Piergiuseppe Agostoni
In conclusion, CRT improved non-uniformity of wall thickening between the LV septal and lateral regions evaluated using QGS, which is predictive of better prognosis in the chronic phase after CRT. PMID: 32493869 [PubMed - in process]
Publication date: Available online 2 June 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Fereshteh Ashtari, Roshanak Mehdipour, Vahid Shaygannejad, Nasrin Asgari
Publication date: Available online 30 May 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Ruth Dobson, Vilija G. Jokubaitis, Gavin Giovannoni
Publication date: June 2020Source: Journal of Hospital Infection, Volume 105, Issue 2Author(s): G. Kampf, M. Suchomel, H. Below, A. Kramer
A New York Times analysis shows why some areas of the United States see reopening as long overdue. A study suggests pregnant women are not at increased risk from the virus. The daily death toll in New York falls again.
This article will summarize the effects of more intensive blood pressure (BP) control on cardiovascular, cognitive, and renal outcomes among elderly (age ≥75 years) individuals at high risk for cardiovascular events. Subsets of patients who may not benefit and obstacles to implementation will be addressed. The authors’ insights will conclude the review. Recent findings A burst of new research regarding the effects of lower BP targets on cardiovascular, cognitive, and renal endpoints among the elderly has been published. Achieved values of 123 mmHg systolic in those without diabetes or prior stroke revealed st...
This study reviews the evidence of increase cardiovascular risk in these women. Recent findings Women with preeclampsia are at two-fold higher risk for development of coronary artery disease, stroke and death, and four-fold increased risk of heart failure. Preeclampsia developed in early part of pregnancy confers greater risk than later in pregnancy. Common factors that predispose women to preeclampsia also confer high risk for developing cardiovascular disease include obesity, metabolic abnormalities, dyslipidaemia, insulin resistance, heightened inflammatory responses, hypercoagulable states and endothelia dysfunction...
Purpose of review Hypertension is a common, modifiable precursor to heart failure. Lifetime risk for development varies across age, sex, race and ability to achieve adequate blood pressure control. Recent findings Although meta-analyses seemingly support intensive blood pressure control to reduce incident heart failure, randomized clinical trials are limited and do not enroll a large number of female, minority, elderly or treatment-resistant patients. Heterogeneity further adds to complexity; however, enhanced cognizance of these disparities can aid clinicians in creating patient-centered care plans. Summary High-r...
ConclusionsOur study supports a healthy lifestyle improving breast cancer prevention, postponing onset of disease, and extending life expectancy among breast cancer patients.